Despite the biological and therapeutic relevance of CDK4/6 for the treatment of HR+, HER2- advanced breast cancer, the detailed mode of action of CDK4/6 inhibitors is not completely understood. Of ...
A33 Fab, is an undeveloped immunotherapeutic fully-humanised antibody candidate that was targeted to the human A33 antigen 1. The fully-humanized A33 Fab was developed by grafting the CDRs from a ...
A research team from the Institute of Statistical Mathematics and Panasonic Holdings Corporation has developed a machine learning algorithm, ShotgunCSP, that enables fast and accurate prediction of ...